Summary
455 serial serum samples from 41 patients with trophoblastic tumour were analysed. Pregnancy-specific beta-1 glycoprotein (SP1), human chorionic gonadotropin (hCG), and placental protein 5 (PP5) were measured by specific radioimmunoassay. Pregnancy-associated α2-glycoprotein (α2-PAG) was measured by electroimmunoassay. SP1 and hCG levels were high in 36 and 35 patients respectively; α2-PAG concentration was also high in 29 patients. PP5 was found only in patients with a hydatidiform mole and it disappeared from serum within a few hours of evacuation. SP1 and hCG levels decreased during the course of the treatment but seronegativity was reached only after some months; hCG was still detectable after that and disappeared from the serum more slowly. Both parameters were sensitive indicators of residual tumour activity and indicated the need more effective treatment some months before clinical manifestations of recurrence became evident. In some patients only one of the tumour markers was present during follow-up, indicating the importance of careful monitoring including the measurement of serum SP1 and hCG levels. A positive correlation between α2-PAG and hCG, SP1 and the clinical course was found only in 80% of patients a finding which demonstrates the limited value of α2-PAG measurements.
Similar content being viewed by others
References
Berne BH, Bohn H, Hofmann R, Klausch B, Straube W, Horne CHW, Kasukawa R, Rittner Ch, Stimson WH, Than GN (1975) Standardisation of nomenclature of pregnancy-associated alpha-2 glycoprotein. Lancet 2: 367–368
Berne BH (1976) Pregnancy-associated alpha-2 glycoprotein levels in pregnancy, oral contraception and and choriocarcinoma. In: Peeters H (ed) Pretides of biological fluids. Pergamon Press, Oxford, pp 165–179
Bohn H (1971) Nachweis und Charakterisierung von Schwangerschaftsproteinen in der menschlichen Placenta sowie ihre quantitative immunologische Bestimmung im Serum schwangerer Frauen. Arch Gynäkol 210: 440–457
Bohn H (1972) Isolierung und Charakterisierung des Schwangerschafts-spezifischen β1-Glykoproteins. Blut 24: 292–302
Bohn H (1974) Untersuchungen über das schwangerschafts-spezifische β1-Glykoprotein. Arch Gynäkol 216: 347–358
Bohn H, Winckler W (1977) Isolierung und Charakterisierung des Plazenta Proteins PP5. Arch Gynäkol 223: 179–186
Goldstein DP (1975) Endocrine assay in chorionic tumours. Clin Obstet Gynecol 18: 41–60
Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15: 45–52
Searle F, Baghsawe KD, Leake BA, Dent J (1979) Serum-SP1-pregnancy-specific-β-glycoprotein in choriocarcinoma and other neoplastic disease. Lancet 1: 579–581
Seppälä M, Rutanen EM, Heikinheimo M, Jalanko H, Engvall E (1978) Detection of trophoblastic tumour activity by pregnancy-specific beta-1 glycoprotein. Int J Cancer 21: 265–267
Stimson WH (1978) Pregnancy-associated α2-glycoprotein and cancer. J R Coll Surg Edinb 23: 253–259
Szabó D, Than G, Csaba I, Karg N (1975) Terhességi alfa-2-globulin, un. “pregnancy protein” izolálása preparativ polyacrylamid elektroforézissel. Kisérl Orvostud 27: 183–188
Tatarinov YS, Falaleeva DM, Kozlyaeva GA, Nikulina DM (1976) Human trophoblastic beta1-globulin and chorioepithelioma. In: Fishman WH, Sell S (eds) Onco-development gene expresson. Academic Press, New York, pp 463–468
Teisner B, Mogensen B, Folkersen J, Svehag SE (1977) Trophoblastic tumour, oral contraceptive therapy and pregnancy-associated alpha2-glycoprotein (PAAG), case report. Br J Obstet Gynaecol 84: 630–632
Than GN, Csaba IF, Szabó DG (1974) An antigen associated with pregnancy. Lancet 2: 1578–1579
Than GN, Csaba IF, Szabó DG, Karg NJ, Novák PF (1975) Quantitative serum levels of pregnancy-associated α2-globulin in patients with benign and malignant tumors. Arch Gynäkol 218: 125–130
Than G (1976) Terhességgel társult alfa-2 glikoprotein — Pregnancy-associated alpha-2 glycoprotein. Dissertation, Pécs, pp 1–225
Than GN, Bohn H, Csaba IF, Karg NJ, Mann V (1978) Pregnancy-specific beta-1 glycoprotein in the sera of patients with trophoblastic diseases. In: Lehmann FG (ed) Carcino-embryonic proteins, chemistry, biology, clinical application, vol 2. Elsevier North Holland, Amsterdam, pp 481–486
Vaitukaitis JL, Braunstein GC, Ross GT (1972) A radioimmunoassay with specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol 113: 751–757
Vaitukaitis JL (1977) Subunit secretion. In: James WHT (ed) Endocrinology, vol 2. Excerpta Medica, Amsterdam, Oxford, pp 104–107
Verceczkey G, Csaba I, Sárdi J (1979) Methotrexate pulse therapy for choriocarcinoma. IRCS Med Sci 7: 459
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Than, G.N., Bohn, H., Csaba, I.F. et al. Placental proteins (SP1, hCG, PP5), and α2-PAG in trophoblastic diseases. Arch. Gynecol. 231, 33–39 (1981). https://doi.org/10.1007/BF02110021
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02110021